News

Let's take immediate steps to make a difference to the lives of gay and bisexual men affected by prostate cancer - that's the recommendation of a report published today by Prostate Cancer UK and Stonewall.

Charity welcomes next step in allowing patient voice to be heard in crucial negotiations.

Prostate Cancer UK responds to news that the National Institute for Health and Clinical Excellence (NICE) has suspended its appraisal of abiraterone for men with incurable prostate cancer who have not yet had chemotherapy.

To mark the launch of our new booklet and DVD, Prostate cancer and your sex life, Psychosexual nurse therapist Lorraine Grover explains why we need to talk about sex.

Prostate Cancer UK is undertaking the first ever national experience survey of men with prostate cancer in Scotland.

Figures released today by Cancer Research UK show that a man’s lifetime risk of being diagnosed with prostate cancer has trebled over 25 years. Dr Sarah Cant, Director of Policy and Campaigns at Prostate Cancer UK, said the figures reinforced the need for the nation to wake up to the growing impact of the disease.

Prostate Cancer UK are delighted that the licence for abiraterone has been extended so that men with advanced prostate cancer can benefit from it at an earlier stage.